|
Index of reports
> Cases with Pruritus (17)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zofran (Ondansetron) where reactions include pruritus. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zofran side effects in male
Reported by a physician from France on 2012-08-24
Patient: male
Reactions: Burning Sensation, Pruritus, Erythema
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Plitican
Dosage: 100mg single dose
Indication: Premedication
Start date: 2012-08-07
End date: 2012-08-07
Zofran
Dosage: 8mg single dose
Indication: Premedication
Start date: 2012-08-07
End date: 2012-08-07
Oxaliplatin
Dosage: 160mg cyclic
Indication: Colorectal Cancer
Start date: 2012-08-07
End date: 2012-08-07
Methylprednisolone
Dosage: 40mg single dose
Indication: Premedication
Start date: 2012-08-07
End date: 2012-08-07
Possible Zofran side effects in female
Reported by a physician from France on 2012-08-17
Patient: female
Reactions: Pruritus, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Dosage: 650mg single dose
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2012-06-06
End date: 2012-06-06
Zofran
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-27
End date: 2012-06-03
Vincristine
Dosage: 2mg see dosage text
Indication: Idiopathic Thrombocytopenic Purpura
Start date: 2012-05-27
End date: 2012-06-03
Potassium Chloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-31
End date: 2012-06-06
Other drugs received by patient: Augmentin '500'; Zolpidem Tartrate; Nplate
Possible Zofran side effects in female
Reported by a physician from France on 2012-08-15
Patient: female
Reactions: Fatigue, Pruritus, Nausea, Faecaloma, Herpes Zoster
Drug(s) suspected as cause:
Ebastine
Indication: Pruritus
Loratadine
Indication: Pruritus
Zantac
Dosage: 50mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Zofran
Dosage: 8mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Neulasta
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-27
Halaven
Dosage: 1.58mg per day
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Solu-Medrol
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-26
Other drugs received by patient: Cyclophosphamide; Fluorouracil; Methotrexate; Nexium; Bevacizumab; Doxorubicin HCL; Acebutolol
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19
Patient: 65 year old female
Reactions: Weight Decreased, Blood Bilirubin Increased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Hypophagia, Alopecia, Dysuria, Feeling Abnormal, Asthenia, DRY Eye, Leukopenia
Drug(s) suspected as cause:
Victrelis
Dosage: 800 mg; tid; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg; qd; po, 25 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Acetaminophen
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: qw; sc
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mcg; prn; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Rythmol
Dosage: 325 mg; bid; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Aspirin
Dosage: 81 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg; bid; po
Administration route: Oral
Pradaxa
Dosage: 150 mg; bid; po, 75 mg; qd; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hydrochloride; Reglan; Metoclopramide
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-19
Patient: 65 year old female
Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Dysphagia, Blood Urine Present, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Feeling Abnormal, DRY Eye, Asthenia, Leukopenia
Drug(s) suspected as cause:
Peginterferon Alfa-2A
Dosage: qw;sc
Indication: Product Used FOR Unknown Indication
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg;prn;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pradaxa
Dosage: 150 mg;bid;po 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Metoclopramide Hydrochloride; Reglan
Possible Zofran side effects in
Reported by a consumer/non-health professional from United States on 2012-04-27
Patient: , weighing 79.5 kg (174.9 pounds)
Reactions: Weight Decreased, Pruritus, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Photophobia, Product Quality Issue, Blood Urine Present, Dysphagia, Stomatitis, Nausea, Underdose, Poor Quality Drug Administered, Eye Pain, Dysgeusia, Blood Glucose Decreased, Bladder Spasm, Vaginal Inflammation, Alopecia, DRY Eye, Asthenia
Drug(s) suspected as cause:
Rythmol SR
Indication: Product Used FOR Unknown Indication
Zofran
Indication: Product Used FOR Unknown Indication
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03
Patient: 65 year old female
Reactions: Blood Bilirubin Increased, Weight Decreased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Stomatitis, Dysphagia, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Hypophagia, Dysuria, DRY Eye, Feeling Abnormal, Asthenia, Leukopenia
Drug(s) suspected as cause:
Pradaxa
Dosage: 150 mg;bid;po 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg;prn;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Tylenol (Caplet)
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: ;qw;sc
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Metoclopramide; Hydrochloride; Reglan
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-03
Patient: 65 year old female
Reactions: Blood Bilirubin Increased, Weight Decreased, Pruritus, Wrong Technique in Drug Usage Process, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Alopecia, Dysuria, Hypophagia, Asthenia, DRY Eye, Feeling Abnormal, Leukopenia
Drug(s) suspected as cause:
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: ;qw;sc
Pradaxa
Dosage: 150 mg;bid;po 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg;prn;po
Administration route: Oral
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Tylenol (Caplet)
Indication: Product Used FOR Unknown Indication
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hydrochloride; Metoclopramide; Reglan
Possible Zofran side effects in 48 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-01
Patient: 48 year old male
Reactions: Overdose, Pruritus, Rash, Epidermolysis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Taxotere
Indication: non-Small Cell Lung Cancer
Start date: 2011-02-23
End date: 2011-03-16
Zofran
Administration route: Oral
Start date: 2010-10-06
End date: 2011-03-20
Emend
Administration route: Oral
Start date: 2011-03-16
End date: 2011-03-18
Prednisolone
Administration route: Oral
Start date: 2010-10-06
End date: 2011-03-20
Possible Zofran side effects in female
Reported by a individual with unspecified qualification from United States on 2012-01-18
Patient: female
Reactions: Tooth Loss, Abdominal Pain, Pruritus, Eczema, Oral Discomfort, Rheumatoid Arthritis, DRY Mouth, Oedema Peripheral, Ileitis, Vertebral Foraminal Stenosis, Back Pain, Melanosis Coli, Osteopenia, Bursitis, Respiratory Tract Congestion, Diverticulum, Increased Tendency To Bruise, Vision Blurred, Left Atrial Dilatation, Abscess, Pyoderma Gangrenosum, Fall, Dermatitis Contact, Intertrigo, Vitreous Floaters, Conjunctivochalasis, Obesity, Rotator Cuff Syndrome, Dyspnoea, Cataract, Excoriation, Joint Dislocation, Varicose Ulceration, Ulnar Neuritis, Syncope, Visual Impairment, Loose Tooth, Gait Disturbance, DRY Eye, Urinary Incontinence, Dementia, Flatulence, Lumbar Spinal Stenosis, Dyspepsia, Electrocardiogram T Wave Abnormal, Ingrowing Nail, Resorption Bone Increased, Radiculopathy, General Physical Health Deterioration, Venous Insufficiency, Hypoaesthesia, Ankle Fracture, Osteonecrosis, Wound Infection Pseudomonas, Joint Swelling, Insomnia, Otitis Media, Colitis, Glaucoma, Pain, Constipation, Gastritis, Fatigue, Bone Loss, Road Traffic Accident, Skin Ulcer, Corneal Dystrophy, Glare, Microangiopathy, Gastrooesophageal Reflux Disease, Pain in JAW, Abdominal Pain Lower, Vulvovaginal Mycotic Infection, Hyponatraemia, Cystitis, Varicose Vein, Facial Pain, Mucosal Inflammation, Anxiety, Diarrhoea, Osteonecrosis of JAW, Deep Vein Thrombosis, Inflammatory Bowel Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zometa
Dosage: 4 mg, daily
Indication: Osteoporosis
Start date: 2005-07-12
End date: 2006-07-06
Zometa
Dosage: 3.3 mg, unk
Zofran
Dosage: 4 mg/2ml, q8h
Other drugs received by patient: Dapsone; Keflex; Vicodin; Meperidine HCL; Imodium; Diovan; Miconazole Nitrate; Clonidine Hydrochloride; Protonix; Omeprazole; Clindamycin; Meclizine; Toradol; Ciprofloxacin; Docusate; Arimidex; Effexor; Gabapentin; Ambien; Citalopram Hydrochloride; Univasc; Triamterene and Hydrochlorothiazide; Furosemide; Venlafaxine; Depo-Medrol; Vytone; Chlordiazepoxide W / Clidinium Bromide; Mobic; Phenergan; Clinoril; Quinine Sulfate; Diphenhydramine HCL; Mytussin DAC; Cephalexin; Norvasc; Diphenoxylate HCL and Atropine Sulfate; Orphenadrine Citrate; Aricept; Acetaminophen and Hydrocodone Bitartrate; Prochlorperazine; Atenolol; Fluoxetine; Spironolactone; Sulindac; Hydrocortisone; Mirapex; Benicar; Compazine; Ancef; Percocet; Naproxen; Sucralfate; Ultram; Desoximetasone; Metoprolol; Orphenadrine Citrate; Tramadol HCL; Nexium; Amoxicillin and Clavulanate Potassium; Lisinopril; Pepcid; Cyclobenzaprine HCL; Miralax; Armodafinil
Possible Zofran side effects in female
Reported by a physician from France on 2012-01-13
Patient: female
Reactions: Pruritus, Rash Erythematous
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vidaza
Indication: Myelodysplastic Syndrome
Start date: 2011-10-10
Zofran
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2011-10-10
Other drugs received by patient: Ezetimibe; Metformin HCL; Bisoprolol Fumarate; Diclofenac; Valsartan; Esidrix
Possible Zofran side effects in 44 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-29
Patient: 44 year old male
Reactions: Pruritus, Rash
Drug(s) suspected as cause:
Rocephin
Start date: 2011-11-29
End date: 2011-12-09
Zofran
Start date: 2011-11-29
End date: 2011-12-09
Zovirax
Start date: 2011-11-29
End date: 2011-12-09
Pantoprazole Sodium
Start date: 2011-11-29
End date: 2011-12-09
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2011-11-29
End date: 2011-12-03
Lamivudine
Start date: 2011-11-29
End date: 2011-12-09
Nystatin
Start date: 2011-11-29
End date: 2011-12-09
Cepacaine
Start date: 2011-11-29
End date: 2011-12-08
Dipyrone TAB
Start date: 2011-11-29
End date: 2011-12-09
Fluconazole
Start date: 2011-12-02
End date: 2011-12-09
Tramadol Hydrochloride
Start date: 2011-11-29
End date: 2011-12-09
Clindamycin
Start date: 2011-11-29
End date: 2011-12-09
Possible Zofran side effects in 48 year old male
Reported by a physician from France on 2011-12-28
Patient: 48 year old male
Reactions: Pruritus, Toxic Epidermal Necrolysis, Rash
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zofran
Administration route: Oral
Indication: Premedication
Start date: 2010-10-06
End date: 2011-03-20
Emend
Administration route: Oral
Indication: Premedication
Start date: 2011-03-16
End date: 2011-03-18
Taxotere
Indication: non-Small Cell Lung Cancer
Start date: 2011-02-23
End date: 2011-03-16
Prednisolone
Indication: Premedication
Start date: 2010-10-06
End date: 2011-03-20
Possible Zofran side effects in 65 year old female
Reported by a individual with unspecified qualification from United States on 2011-12-16
Patient: 65 year old female
Reactions: Weight Decreased, Blood Bilirubin Increased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Blood Urine Present, Dysphagia, Stomatitis, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Dysuria, Alopecia, Hypophagia, Asthenia, Feeling Abnormal, DRY Eye, Leukopenia
Drug(s) suspected as cause:
Ribavirin
Dosage: 600 mg;bid;po
Administration route: Oral
Pradaxa
Dosage: 150 mg;bid;po, 75 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Nuvigil
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Zofran
Dosage: 8 mg; pan; po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Peginterferon Alfa-2A
Dosage: ;qw;sc
Acetaminophen
Indication: Product Used FOR Unknown Indication
Victrelis
Dosage: 800 mg;tid;po
Indication: Product Used FOR Unknown Indication
Toprol-XL
Dosage: 50 mg;qd;po, 25 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Aspirin
Dosage: 81 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cozaar
Dosage: 50 mg;qd;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Rythmol
Dosage: 325 mg;bid;po
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Metoclopramide HCL; Reglan
Possible Zofran side effects in 13 year old male
Reported by a physician from United States on 2011-10-20
Patient: 13 year old male, weighing 39.6 kg (87.1 pounds)
Reactions: Anxiety, Abdominal Pain, Pruritus, Chills, Anger
Drug(s) suspected as cause:
PEG-Asparaginase
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Benadryl
Indication: Product Used FOR Unknown Indication
Ranitidine
Indication: Product Used FOR Unknown Indication
Bactrim
Indication: Product Used FOR Unknown Indication
Velcade
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Zofran
Indication: Product Used FOR Unknown Indication
Prednisone
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Doxorubicin HCL
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Vincristine
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-09-08
Other drugs received by patient: Ativan; Methotrexate; Hydrocortisone; Cytarabine; Scopolamine
Possible Zofran side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-11
Patient: 65 year old female, weighing 79.4 kg (174.6 pounds)
Reactions: Blood Bilirubin Increased, Weight Decreased, Wrong Technique in Drug Usage Process, Pruritus, Treatment Noncompliance, Transaminases Increased, Stomatitis, Dysphagia, Blood Urine Present, Tablet Physical Issue, Anaemia, Poor Quality Drug Administered, Vulvovaginal Pain, Eye Irritation, Upper-Airway Cough Syndrome, Somnolence, Haemorrhoidal Haemorrhage, Photophobia, Sinusitis, Nausea, Haemorrhoids, Underdose, Eye Pain, Blood Glucose Decreased, Dysgeusia, Product Packaging Issue, Disease Recurrence, Hypophagia, Alopecia, Dysuria, Feeling Abnormal, DRY Eye, Asthenia, Leukopenia
Drug(s) suspected as cause:
Cozaar
Dosage: 50 mg daily
Indication: Hypertension
Aspirin
Dosage: 81 mg daily, oral
Administration route: Oral
Peginterferon Alfa-2A
Dosage: 180 microgram/0.5 ml,1 each friday night ; 180 microgram/ml weekly, subcutaneous
Indication: Hepatitis C
Start date: 2005-09-01
End date: 2006-02-01
Peginterferon Alfa-2A
Dosage: 180 microgram/0.5 ml,1 each friday night ; 180 microgram/ml weekly, subcutaneous
Indication: Hepatitis C
Start date: 2011-07-29
Victrelis
Dosage: 200 mg (four thrice daily),oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-26
Pradaxa
Dosage: 150 mg am and pm, oral ; 75mg daily, oral
Administration route: Oral
Indication: Anticoagulant Therapy
Toprol-XL
Dosage: 50 mg once daily,oral ; 25mg daily, oral
Administration route: Oral
Indication: Hypertension
Start date: 2008-01-01
Acetaminophen
Nuvigil
Dosage: 50mg daily, oral
Administration route: Oral
Ribavirin
Dosage: 600 mg, one in am and pm ; 600mg am and 400mg pm, oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-23
Ribavirin
Dosage: 600 mg, one in am and pm ; 600mg am and 400mg pm, oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2005-09-01
End date: 2006-02-01
Ribavirin
Dosage: 600 mg, one in am and pm ; 600mg am and 400mg pm, oral
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-29
Zofran
Dosage: 8 mg (one every 12 hrs as needed), oral
Administration route: Oral
Indication: Nausea
Start date: 2011-08-26
Rythmol SR (Propaphenone Hcl)
Dosage: 325 mg (am and pm each),oral
Administration route: Oral
Indication: Atrial Fibrillation
Start date: 2008-01-01
Other drugs received by patient: Calcium Carbonate; Metoclopramide Hydrochloride; Fish OIL with Omega3 Fatty Acids; Multi-Vitamins; Calcium Plus Vitamin D; Reglan
Possible Zofran side effects in 13 year old male
Reported by a physician from United States on 2011-10-10
Patient: 13 year old male, weighing 39.6 kg (87.1 pounds)
Reactions: Anxiety, Confusional State, Akathisia, Pruritus, Pain, Chills, Anger, Memory Impairment, Paraesthesia
Drug(s) suspected as cause:
Methotrexate
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Pegaspargase
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Zofran
Indication: Product Used FOR Unknown Indication
Vincristine
Dosage: 1.5mgm2 cyclic
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Bactrim
Indication: Product Used FOR Unknown Indication
Ranitidine
Indication: Product Used FOR Unknown Indication
Prednisone
Dosage: 20mgm2 cyclic
Administration route: Oral
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Benadryl
Indication: Product Used FOR Unknown Indication
Cytarabine
Indication: Precursor B-Lymphoblastic Lymphoma
Hydrocortisone
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Ativan
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3mgm2 cyclic
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Doxorubicin HCL
Dosage: 60mgm2 cyclic
Indication: Precursor B-Lymphoblastic Lymphoma
Start date: 2011-09-08
Scopolamine
Indication: Product Used FOR Unknown Indication
|
